COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer

Publication date: Available online 8 October 2020Source: European Journal of RadiologyAuthor(s): Tao Yu

Source: European Journal of Radiology - October 10, 2020 Category: Radiology Source Type: research